IP Library Granted Patent US 11,420,927
Granted Patent B2
US 11,420,927 · App. 14/409,522 · Granted Aug 23, 2022

Process for the manufacture of alkylfluoroacrylate

Inventors: Peter Kapitan (Linz, AT); Alexander Sajtos (Leonding, AT)
Assignee: Patheon Austria GMBH & Co KG
C07C67/54C07C67/32C07C67/343C07C67/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,420,927
App. No.
14/409,522
Granted
Aug 23, 2022
Kind
B2
Abstract

The invention relates to a process for the manufacture of an alkylfluoroacrylate starting from alkylfluoroacetate and an oxalic acid ester, wherein an alkane liquid under the reaction conditions is applied as the solvent in one of the reaction steps.

Claims (15)

1. A process for the manufacture of a methylfluoroacrylate, comprising the following steps:

A. a methylfluoroacetate with an ester of oxalic acid is reacted in the presence of a base and a suitable solvent in a crossed Claisen condensation reaction resulting in a Claisen salt;

B. the Claisen salt obtained in step A is optionally filtered off and washed with a suitable solvent;

C. the Claisen salt obtained in step A or B is reacted with paraformaldehyde in a suitable solvent;

D. the methylfluoroacrylate obtained in step C is isolated using a suitable solvent, wherein the methylfluoroacrylate isolated after distillation has a purity of at least 99.5 wt %, contains below 0.5 wt % methylfluoroacetate and below 2.0 wt % dimethyl carbonate;

wherein the solvent in at least steps C and D and optionally in one of steps A or B is an alkane selected from a group consisting of pentane and hexane.

2. The process according to claim 1 , wherein the alkane is pentane.

3. The process according to claim 1 or 2 , wherein the solvent in steps C and D comprises the alkane.

4. The process according to claim 1 , wherein the ester of oxalic acid is dimethyloxalate.

5. The process according to claim 1 , wherein the base in the Claisen condensation reaction is a metal alkoxide represented by the formula MOR, wherein M is sodium or potassium and R is a C 1 -C 4 alkyl group.

6. The process according to claim 1 , wherein the base in the Claisen condensation reaction is a metal alkoxide of the formula MOR in a C 1 -C 4 alcohol.

7. The process according to claim 1 , wherein the base is sodium methoxide in methanol.

8. The process according to claim 1 , wherein the solvent in step A is methyl-tert-butylether or pentane.

9. The process according to claim 1 , wherein methylfluoroacrylate obtained after the reaction with paraformaldehyde is quenched with water before isolation.

10. The process according to claim 1 , wherein the isolation comprises a filtration and a distillation.

Assignments (2)
CHANGE OF NAME Recorded Mar 27, 2017
From: DPX FINE CHEMICALS AUSTRIA GMBH & CO KG
To: PATHEON AUSTRIA GMBH & CO KG
Reel/Frame 041752/0464 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2016
From: KAPITAN, PETER; SAJTOS, ALEXANDER
To: DPX FINE CHEMICALS AUSTRIA GMBH & CO KG
Reel/Frame 038705/0935 →
Priority Claims (1)
EP 12173485 · Jun 25, 2012 · regional
Continuity (1)
Related Publication 20150368178A1 · Dec 24, 2015